News & Insights
A place to read about our company and team achievements, patient stories, case studies, events and more!
Patient Story: Kevin Quinn
April 6th, 2023
In 2022, Kevin Quinn from Liverpool joined a uMed supported study of patients with chronic respiratory conditions. The study evaluated the effectiveness of a respiratory monitor that measures CO2 levels in tidal breathing of participants. The aim of the research was to help advance the development of point-of-care diagnostic technologies that monitor and manage cardiorespiratory…
MCI Onehealth Partners with uMed to Accelerate Clinical Research
March 10th, 2023
Partnership introduces unique patient recruitment and engagement platform to Canada TORONTO, March 09, 2023 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, and uMed, the UK-based provider of a leading automated patient-recruitment platform, are pleased to announce a partnership…
First of its kind patient cohort program announced at IPF-Summit
August 29th, 2022
NEW YORK, August 29, 2022 — A first-of-its-kind patient cohort platform will soon be available to UK and US researchers struggling to recruit patients with interstitial lung disease (ILD), such as pulmonary fibrosis and progressing fibrosis resulting from COVID-19. UK-based company uMed announced the launch of the Access-ILD/PF Cohort at the sixth annual Idiopathic Pulmonary…
Finding the Right Patients for Primary Care Clinical Studies
October 5th, 2021
An article published in the Journal of Clinical Studies describing the benefits of uMed in clinical trial recruitment
Automated recruitment platform accelerates patients into clinical studies
September 9th, 2021
An automated patient recruitment platform (ARP) could help researchers recruit patients significantly faster into clinical studies across diverse disease areas, helping researchers identify new treatments for diseases more quickly, tech platform creator uMed says.
Q&A with Dr Matt Wilson, founder, uMed
March 23rd, 2021
Pharma Business International features uMed CEO Matt Wilson. He discusses uMed’s growth as a health technology company and the importance of building trust with all stakeholders.
uMed raises $4.8m in venture capital funding
November 30th, 2020
uMed raises $4.8m in venture capital funding to help healthcare providers participate in more clinical studies.
Three tech start-ups actively fighting coronavirus
April 16th, 2020
Growth Business highlights 3 tech start-ups actively fighting the Covid-19 pandemic that are open for investment to fund further research and development.
uMed feature in the 100 HealthTech Pioneers of 2020
February 14th, 2020
We are excited to share uMed are in the Top 20 of the BusinessCloud’s 100 HealthTech Pioneers ranking for 2020! Well done to the uMed team for all their continued hard work!
Patient privacy is driving the digital healthcare agenda
January 30th, 2020
uMed’s Ian Wootton joined the debate on Integrated Healthcare, hosted by the UKs Department for International Trade at Arab Health.